• Latest Posts

Belgian Biotech to Abandon Phase III Cell Therapy Trial for Bone Disease

Belgian Firm Will Develop Antibiotic Alternatives for Industrial Biotech Using CRISPR

Startup Scout 12 Oct 2018

This Biotech is the First to Work on Antivirals for Farm Livestock

Update: Series A Boost Pushes Belgian Microbiome Spin-Off Forward

Cell Therapy Helps Regenerate Difficult Bone Fractures

ADVERTISEMENT

The EMA Approves the First Nanobody from Ablynx

Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema

A New HIV Vaccine Could Protect Patients Against Multiple Viral Strains

Massive Series B Funding Could Bring Belgian Immuno-oncology Treatments Into the Clinic

More News! 17 May 2018

The First In-Human Trial of an Eye Implant Helps Patients With Glaucoma

“This is the First Time CAR-T Has Ever Worked on Acute Myeloid Leukemia“

ADVERTISEMENT